# Optimizing the Seahorse XF Mito Stress Test Workflow and Troubleshooting Notes: A Stepwise Protocol for HUVECs

**Authors:** Jingyi Wang, Yue Jiao, Jingzhe Li, Yanyan Ma, Changzhen Liu, Jing Yang

PMC · DOI: 10.3390/metabo16020099 · Metabolites · 2026-01-28

## TL;DR

This paper provides a detailed, optimized protocol for measuring mitochondrial and glycolytic function in HUVECs using the Seahorse XF Pro Analyzer.

## Contribution

The paper introduces a step-by-step workflow that preserves HUVECs in their native adherent state, improving efficiency and reproducibility.

## Key findings

- The protocol reduces operator error by addressing overlooked practical challenges in standard manuals.
- It enables real-time, label-free metabolic profiling of HUVECs without cell detachment.
- The method supports reproducible results in vascular aging and cardiovascular research.

## Abstract

This protocol details an optimized step-by-step procedure for performing the Seahorse XF Cell Mito Stress Test on human umbilical vein endothelial cells (HUVECs) using the Agilent Seahorse XF Pro Analyzer. Designed to address practical challenges often overlooked in standard manuals, the method preserves the native adherent state of HUVECs—a key in vitro model in vascular aging (VA) research—enabling real-time, label-free measurement of mitochondrial respiration and glycolytic function without cell detachment. The workflow is presented chronologically, covering instrument preparation, cell seeding, compound loading, assay execution, and post-assay normalization, with integrated notes and troubleshooting tips refined through hands-on experience based on the official manuals. This protocol aims to set up a detailed, rearranged standard workflow to improve experimental efficiency, reduce operator error, and support reproducible and well-organized metabolic profiling of HUVECs in aging and cardiovascular studies.

## Linked entities

- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** BLNK (B cell linker) [NCBI Gene 29760] {aka AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** injury to (MESH:D014947), mitochondrial impairment (MESH:D028361), DFSC-EC-01 (MESH:D055954), ) dysfunction (MESH:D006331), CVDs (MESH:D002318)
- **Chemicals:** Resveratrol (MESH:D000077185), FCCP (MESH:D002259), water (MESH:D014867), Ginsenoside Rg1 (MESH:C035054), Carbonyl Cyanide-4-(Trifluoromethoxy) Phenylhydrazone (MESH:C108897), pyruvate (MESH:D019289), oxygen (MESH:D010100), P (MESH:D010758), oligomycin (MESH:D009840), glucose (MESH:D005947), L-Glutamine (MESH:D005973), bicinchoninic acid (MESH:C047117), CO2 (MESH:D002245), rotenone (MESH:D012402), ATP (MESH:D000255), antimycin A (MESH:D000968), Notoginsenoside R1 (MESH:C072936), S (MESH:D013455), Seahorse XF DMEM medium (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** XF — Xenopus laevis (African clawed frog), Spontaneously immortalized cell line (CVCL_6E64), PC0020 — Homo sapiens (Human), Nephropathic cystinosis, Finite cell line (CVCL_Y982), SW-CJ- — Homo sapiens (Human), Diffuse large B-cell lymphoma germinal center B-cell type, Cancer cell line (CVCL_UI83), HUVEC — Homo sapiens (Human), Finite cell line (CVCL_3722), XFe96 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_8609)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942731/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12942731/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942731/full.md

---
Source: https://tomesphere.com/paper/PMC12942731